Back
SpringWorks Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
44
SWTX
SpringWorks Therapeutics
Last Price:
38.09
Seasonality Move:
-1.67%
Sell
40
ALNY
Alnylam Pharmaceuticals
Last Price:
235.09
Seasonality Move:
1.34%
Sell
44
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
- The current SpringWorks Therapeutics [SWTX] share price is $38.04. The Score for SWTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $234.84. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $38.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $234.84
The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 48.13 | Sell |
| Chaikin Money Flow: | 178963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.27 - 39.85) | Sell |
| Bollinger Bands (100): | (38.31 - 47.41) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.85 | Buy |
| Relative Strength Index (14 RSI): | 56.7 | Buy |
| Chaikin Money Flow: | -308054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (223.66 - 259.84) | Sell |
| Bollinger Bands (100): | (132.34 - 213.88) | Buy |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.4 | Buy |
| 20-day SMA: | 38.46 | Sell |
| 50-day SMA: | 39.43 | Sell |
| 200-day SMA: | 38.52 | Sell |
| 8-day EMA: | 37.77 | Buy |
| 20-day EMA: | 38.25 | Sell |
| 50-day EMA: | 39.5 | Sell |
| 200-day EMA: | 38.77 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 236.7 | Sell |
| 20-day SMA: | 246.13 | Sell |
| 50-day SMA: | 196.95 | Buy |
| 200-day SMA: | 172.44 | Buy |
| 8-day EMA: | 238.44 | Sell |
| 20-day EMA: | 234.68 | Buy |
| 50-day EMA: | 209.36 | Buy |
| 200-day EMA: | 181.57 | Buy |
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $1.45 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.34 per share, and an increase next year of $1.84 per share.
SpringWorks Therapeutics Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||